Serum aminotransferases, namely alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT), are commonly used as non-invasive markers of hepatic injury in NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.